Ten-year surveillance study of ventilator-associated pneumonia at a tertiary care center in Lebanon. Issue 4 (July 2019)

• Record Type: Journal Article
• Authors: Kanafani, Zeina A.; El Zakhem, Aline; Zahreddine, Nada; Ahmadieh, Rihab; Kanj, Souha S.
• Is Part Of: Journal of infection and public health. Volume 12:Issue 4(2019)
• Page Start: 492
• Page End: 495
• Publication Date: 2019-07
• Subjects: Ventilator -- Pneumonia -- Intensive care -- Acinetobacter -- Lebanon; Communicable diseases -- Periodicals; Public health -- Periodicals; Epidemiology -- Periodicals; Nosocomial infections -- Prevention -- Periodicals; Medical microbiology -- Periodicals; 614.4
• DOI: 10.1016/j.jiph.2019.01.057
• Languages: English
• ISSNs: 1876-0341

Abstract

Abstract: Background: Ventilator-associated pneumonia (VAP) is associated with significant adverse outcomes in critically-ill patients admitted to the Intensive Care Unit (ICU). Systematic data from Lebanon on VAP are not available and large epidemiological studies from the region are scarce. Methods: We conducted a retrospective study over a 10-year period at the American University of Beirut Medical Center (AUBMC), a tertiary referral center in Lebanon in order to describe the incidence, microbiology, and temporal trends of VAP in the medical/surgical ICU. Results: A total of 162 patients developed VAP over the study period and the overall incidence of VAP was 7.9 per 1000 ventilator-days. There was a statistically significant decrease over time in the incidence of VAP, from 13.1 in 2008 to 1.1 per 1000 ventilator-days in 2017. Multidrug-resistant (MDR) Acinetobacter spp. was the predominant pathogen, both in early- as well as late-onset VAP, followed by Pseudomonas aeruginosa . Conclusions: Following significant efforts from the Infection Control and Prevention Program, a considerable reduction in the incidence of VAP was achieved at AUBMC. The predominance of MDR Acinetobacter spp. should be taken into consideration when deciding on empirical therapy in patients with VAP.